Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer

Gastric cancer (GC) is characterized by unique genetic aberrations. Some of these mutations may be used to predict tumor prognosis or to guide patient therapy. Cell-free circulating tumor DNA (ctDNA) has been considered a promising alternative to biopsy to identify genome aberrations. However, no st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Jing, Lu, Yaping, Guan, Yanfang, Chang, Lianpeng, Yu, Zhengyuan, Qian, Haixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039113/
https://www.ncbi.nlm.nih.gov/pubmed/32194723
http://dx.doi.org/10.3892/ol.2020.11305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039113/
https://www.ncbi.nlm.nih.gov/pubmed/32194723
http://dx.doi.org/10.3892/ol.2020.11305

Ejemplares similares